nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicardipine—CYP2E1—Dacarbazine—pancreatic cancer	0.0501	0.0802	CbGbCtD
Nicardipine—CYP2E1—Tamoxifen—pancreatic cancer	0.0399	0.0638	CbGbCtD
Nicardipine—CYP2B6—Tamoxifen—pancreatic cancer	0.0393	0.063	CbGbCtD
Nicardipine—CYP3A5—Tamoxifen—pancreatic cancer	0.031	0.0496	CbGbCtD
Nicardipine—CYP2B6—Irinotecan—pancreatic cancer	0.0302	0.0483	CbGbCtD
Nicardipine—CYP2C8—Tamoxifen—pancreatic cancer	0.0298	0.0477	CbGbCtD
Nicardipine—CYP3A5—Erlotinib—pancreatic cancer	0.0263	0.0422	CbGbCtD
Nicardipine—CYP2C8—Erlotinib—pancreatic cancer	0.0253	0.0405	CbGbCtD
Nicardipine—CYP2C19—Tamoxifen—pancreatic cancer	0.025	0.04	CbGbCtD
Nicardipine—CYP3A5—Irinotecan—pancreatic cancer	0.0238	0.0381	CbGbCtD
Nicardipine—CYP2C8—Fluorouracil—pancreatic cancer	0.022	0.0351	CbGbCtD
Nicardipine—CYP2C9—Tamoxifen—pancreatic cancer	0.0208	0.0333	CbGbCtD
Nicardipine—ABCB1—Tamoxifen—pancreatic cancer	0.0202	0.0323	CbGbCtD
Nicardipine—CYP2D6—Tamoxifen—pancreatic cancer	0.019	0.0304	CbGbCtD
Nicardipine—CYP3A5—Docetaxel—pancreatic cancer	0.0174	0.0279	CbGbCtD
Nicardipine—ABCB1—Gemcitabine—pancreatic cancer	0.0174	0.0278	CbGbCtD
Nicardipine—CYP3A5—Sunitinib—pancreatic cancer	0.0174	0.0278	CbGbCtD
Nicardipine—ABCB1—Erlotinib—pancreatic cancer	0.0171	0.0274	CbGbCtD
Nicardipine—CYP2B6—Doxorubicin—pancreatic cancer	0.0165	0.0264	CbGbCtD
Nicardipine—CYP2D6—Erlotinib—pancreatic cancer	0.0162	0.0259	CbGbCtD
Nicardipine—ABCB1—Irinotecan—pancreatic cancer	0.0155	0.0248	CbGbCtD
Nicardipine—CYP2C9—Fluorouracil—pancreatic cancer	0.0153	0.0245	CbGbCtD
Nicardipine—CYP3A4—Tamoxifen—pancreatic cancer	0.0121	0.0193	CbGbCtD
Nicardipine—ABCB1—Docetaxel—pancreatic cancer	0.0113	0.0182	CbGbCtD
Nicardipine—ABCB1—Sunitinib—pancreatic cancer	0.0113	0.0181	CbGbCtD
Nicardipine—CYP3A4—Erlotinib—pancreatic cancer	0.0103	0.0164	CbGbCtD
Nicardipine—CYP3A4—Irinotecan—pancreatic cancer	0.00928	0.0148	CbGbCtD
Nicardipine—ABCB1—Doxorubicin—pancreatic cancer	0.00846	0.0135	CbGbCtD
Nicardipine—CYP2D6—Doxorubicin—pancreatic cancer	0.00797	0.0128	CbGbCtD
Nicardipine—CYP3A4—Docetaxel—pancreatic cancer	0.0068	0.0109	CbGbCtD
Nicardipine—CYP3A4—Sunitinib—pancreatic cancer	0.00677	0.0108	CbGbCtD
Nicardipine—CYP3A4—Doxorubicin—pancreatic cancer	0.00507	0.00811	CbGbCtD
Nicardipine—Nimodipine—AHR—pancreatic cancer	0.00191	1	CrCbGaD
Nicardipine—Confusional state—Fluorouracil—pancreatic cancer	0.000324	0.00181	CcSEcCtD
Nicardipine—Abdominal pain—Sunitinib—pancreatic cancer	0.000322	0.00179	CcSEcCtD
Nicardipine—Body temperature increased—Sunitinib—pancreatic cancer	0.000322	0.00179	CcSEcCtD
Nicardipine—Diarrhoea—Erlotinib—pancreatic cancer	0.000322	0.00179	CcSEcCtD
Nicardipine—Oedema peripheral—Docetaxel—pancreatic cancer	0.000322	0.00179	CcSEcCtD
Nicardipine—Oedema—Fluorouracil—pancreatic cancer	0.000321	0.00179	CcSEcCtD
Nicardipine—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.00032	0.00178	CcSEcCtD
Nicardipine—Infection—Fluorouracil—pancreatic cancer	0.000319	0.00178	CcSEcCtD
Nicardipine—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000316	0.00176	CcSEcCtD
Nicardipine—Hot flush—Doxorubicin—pancreatic cancer	0.000315	0.00175	CcSEcCtD
Nicardipine—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000315	0.00175	CcSEcCtD
Nicardipine—Visual impairment—Docetaxel—pancreatic cancer	0.000315	0.00175	CcSEcCtD
Nicardipine—Dizziness—Tamoxifen—pancreatic cancer	0.000315	0.00175	CcSEcCtD
Nicardipine—Tachycardia—Fluorouracil—pancreatic cancer	0.000314	0.00175	CcSEcCtD
Nicardipine—Hypotension—Irinotecan—pancreatic cancer	0.000314	0.00175	CcSEcCtD
Nicardipine—Menopausal symptoms—Doxorubicin—pancreatic cancer	0.000312	0.00174	CcSEcCtD
Nicardipine—Dizziness—Erlotinib—pancreatic cancer	0.000311	0.00173	CcSEcCtD
Nicardipine—Face oedema—Epirubicin—pancreatic cancer	0.000307	0.00171	CcSEcCtD
Nicardipine—Hypotension—Gemcitabine—pancreatic cancer	0.000306	0.0017	CcSEcCtD
Nicardipine—Insomnia—Irinotecan—pancreatic cancer	0.000304	0.00169	CcSEcCtD
Nicardipine—Flushing—Docetaxel—pancreatic cancer	0.000303	0.00169	CcSEcCtD
Nicardipine—Vomiting—Tamoxifen—pancreatic cancer	0.000302	0.00169	CcSEcCtD
Nicardipine—Paraesthesia—Irinotecan—pancreatic cancer	0.000301	0.00168	CcSEcCtD
Nicardipine—Hypotension—Fluorouracil—pancreatic cancer	0.0003	0.00167	CcSEcCtD
Nicardipine—Hypersensitivity—Sunitinib—pancreatic cancer	0.0003	0.00167	CcSEcCtD
Nicardipine—Rash—Tamoxifen—pancreatic cancer	0.0003	0.00167	CcSEcCtD
Nicardipine—Dermatitis—Tamoxifen—pancreatic cancer	0.0003	0.00167	CcSEcCtD
Nicardipine—Vomiting—Erlotinib—pancreatic cancer	0.000299	0.00167	CcSEcCtD
Nicardipine—Dyspnoea—Irinotecan—pancreatic cancer	0.000299	0.00167	CcSEcCtD
Nicardipine—Somnolence—Irinotecan—pancreatic cancer	0.000298	0.00166	CcSEcCtD
Nicardipine—Headache—Tamoxifen—pancreatic cancer	0.000298	0.00166	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000298	0.00166	CcSEcCtD
Nicardipine—Rash—Erlotinib—pancreatic cancer	0.000297	0.00165	CcSEcCtD
Nicardipine—Dermatitis—Erlotinib—pancreatic cancer	0.000297	0.00165	CcSEcCtD
Nicardipine—Insomnia—Gemcitabine—pancreatic cancer	0.000296	0.00165	CcSEcCtD
Nicardipine—Dyspepsia—Irinotecan—pancreatic cancer	0.000295	0.00165	CcSEcCtD
Nicardipine—Headache—Erlotinib—pancreatic cancer	0.000295	0.00164	CcSEcCtD
Nicardipine—Paraesthesia—Gemcitabine—pancreatic cancer	0.000294	0.00164	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000293	0.00163	CcSEcCtD
Nicardipine—Asthenia—Sunitinib—pancreatic cancer	0.000292	0.00163	CcSEcCtD
Nicardipine—Dyspnoea—Gemcitabine—pancreatic cancer	0.000291	0.00162	CcSEcCtD
Nicardipine—Orthostatic hypotension—Epirubicin—pancreatic cancer	0.000291	0.00162	CcSEcCtD
Nicardipine—Insomnia—Fluorouracil—pancreatic cancer	0.000291	0.00162	CcSEcCtD
Nicardipine—Somnolence—Gemcitabine—pancreatic cancer	0.000291	0.00162	CcSEcCtD
Nicardipine—Hypokalaemia—Epirubicin—pancreatic cancer	0.00029	0.00161	CcSEcCtD
Nicardipine—Paraesthesia—Fluorouracil—pancreatic cancer	0.000289	0.00161	CcSEcCtD
Nicardipine—Constipation—Irinotecan—pancreatic cancer	0.000287	0.0016	CcSEcCtD
Nicardipine—Pain—Irinotecan—pancreatic cancer	0.000287	0.0016	CcSEcCtD
Nicardipine—Dyspnoea—Fluorouracil—pancreatic cancer	0.000287	0.0016	CcSEcCtD
Nicardipine—Somnolence—Fluorouracil—pancreatic cancer	0.000286	0.00159	CcSEcCtD
Nicardipine—Face oedema—Doxorubicin—pancreatic cancer	0.000284	0.00158	CcSEcCtD
Nicardipine—Dyspepsia—Fluorouracil—pancreatic cancer	0.000283	0.00158	CcSEcCtD
Nicardipine—Nausea—Tamoxifen—pancreatic cancer	0.000283	0.00157	CcSEcCtD
Nicardipine—Pain—Gemcitabine—pancreatic cancer	0.00028	0.00156	CcSEcCtD
Nicardipine—Constipation—Gemcitabine—pancreatic cancer	0.00028	0.00156	CcSEcCtD
Nicardipine—Nausea—Erlotinib—pancreatic cancer	0.00028	0.00156	CcSEcCtD
Nicardipine—Diarrhoea—Sunitinib—pancreatic cancer	0.000279	0.00155	CcSEcCtD
Nicardipine—Feeling abnormal—Irinotecan—pancreatic cancer	0.000277	0.00154	CcSEcCtD
Nicardipine—Pain—Fluorouracil—pancreatic cancer	0.000275	0.00153	CcSEcCtD
Nicardipine—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000274	0.00153	CcSEcCtD
Nicardipine—Dizziness—Sunitinib—pancreatic cancer	0.000269	0.0015	CcSEcCtD
Nicardipine—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000269	0.0015	CcSEcCtD
Nicardipine—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.000269	0.0015	CcSEcCtD
Nicardipine—Hypokalaemia—Doxorubicin—pancreatic cancer	0.000268	0.00149	CcSEcCtD
Nicardipine—Angina pectoris—Epirubicin—pancreatic cancer	0.000268	0.00149	CcSEcCtD
Nicardipine—Body temperature increased—Irinotecan—pancreatic cancer	0.000265	0.00148	CcSEcCtD
Nicardipine—Abdominal pain—Irinotecan—pancreatic cancer	0.000265	0.00148	CcSEcCtD
Nicardipine—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000265	0.00148	CcSEcCtD
Nicardipine—Vomiting—Sunitinib—pancreatic cancer	0.000259	0.00144	CcSEcCtD
Nicardipine—Body temperature increased—Gemcitabine—pancreatic cancer	0.000258	0.00144	CcSEcCtD
Nicardipine—Rash—Sunitinib—pancreatic cancer	0.000257	0.00143	CcSEcCtD
Nicardipine—Dermatitis—Sunitinib—pancreatic cancer	0.000257	0.00143	CcSEcCtD
Nicardipine—Headache—Sunitinib—pancreatic cancer	0.000255	0.00142	CcSEcCtD
Nicardipine—Syncope—Docetaxel—pancreatic cancer	0.000255	0.00142	CcSEcCtD
Nicardipine—Pollakiuria—Epirubicin—pancreatic cancer	0.000254	0.00142	CcSEcCtD
Nicardipine—Body temperature increased—Fluorouracil—pancreatic cancer	0.000254	0.00142	CcSEcCtD
Nicardipine—Palpitations—Docetaxel—pancreatic cancer	0.000251	0.0014	CcSEcCtD
Nicardipine—Loss of consciousness—Docetaxel—pancreatic cancer	0.00025	0.00139	CcSEcCtD
Nicardipine—Angina pectoris—Doxorubicin—pancreatic cancer	0.000248	0.00138	CcSEcCtD
Nicardipine—Hypersensitivity—Irinotecan—pancreatic cancer	0.000247	0.00138	CcSEcCtD
Nicardipine—Hypertension—Docetaxel—pancreatic cancer	0.000245	0.00137	CcSEcCtD
Nicardipine—Arthralgia—Docetaxel—pancreatic cancer	0.000242	0.00135	CcSEcCtD
Nicardipine—Chest pain—Docetaxel—pancreatic cancer	0.000242	0.00135	CcSEcCtD
Nicardipine—Myalgia—Docetaxel—pancreatic cancer	0.000242	0.00135	CcSEcCtD
Nicardipine—Nausea—Sunitinib—pancreatic cancer	0.000242	0.00135	CcSEcCtD
Nicardipine—Asthenia—Irinotecan—pancreatic cancer	0.000241	0.00134	CcSEcCtD
Nicardipine—Conjunctivitis—Epirubicin—pancreatic cancer	0.000239	0.00133	CcSEcCtD
Nicardipine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000237	0.00132	CcSEcCtD
Nicardipine—Dry mouth—Docetaxel—pancreatic cancer	0.000237	0.00132	CcSEcCtD
Nicardipine—Sweating—Epirubicin—pancreatic cancer	0.000235	0.00131	CcSEcCtD
Nicardipine—Pollakiuria—Doxorubicin—pancreatic cancer	0.000235	0.00131	CcSEcCtD
Nicardipine—Asthenia—Gemcitabine—pancreatic cancer	0.000235	0.00131	CcSEcCtD
Nicardipine—Haematuria—Epirubicin—pancreatic cancer	0.000234	0.0013	CcSEcCtD
Nicardipine—Confusional state—Docetaxel—pancreatic cancer	0.000234	0.0013	CcSEcCtD
Nicardipine—Oedema—Docetaxel—pancreatic cancer	0.000232	0.00129	CcSEcCtD
Nicardipine—Infection—Docetaxel—pancreatic cancer	0.000231	0.00128	CcSEcCtD
Nicardipine—Sinusitis—Epirubicin—pancreatic cancer	0.00023	0.00128	CcSEcCtD
Nicardipine—Diarrhoea—Irinotecan—pancreatic cancer	0.00023	0.00128	CcSEcCtD
Nicardipine—Shock—Docetaxel—pancreatic cancer	0.000228	0.00127	CcSEcCtD
Nicardipine—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000227	0.00127	CcSEcCtD
Nicardipine—Tachycardia—Docetaxel—pancreatic cancer	0.000226	0.00126	CcSEcCtD
Nicardipine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000224	0.00125	CcSEcCtD
Nicardipine—Dizziness—Irinotecan—pancreatic cancer	0.000222	0.00124	CcSEcCtD
Nicardipine—Rhinitis—Epirubicin—pancreatic cancer	0.000221	0.00123	CcSEcCtD
Nicardipine—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000221	0.00123	CcSEcCtD
Nicardipine—Diarrhoea—Fluorouracil—pancreatic cancer	0.00022	0.00123	CcSEcCtD
Nicardipine—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000219	0.00122	CcSEcCtD
Nicardipine—Sweating—Doxorubicin—pancreatic cancer	0.000218	0.00121	CcSEcCtD
Nicardipine—Oedema peripheral—Epirubicin—pancreatic cancer	0.000217	0.00121	CcSEcCtD
Nicardipine—Hypotension—Docetaxel—pancreatic cancer	0.000217	0.00121	CcSEcCtD
Nicardipine—Haematuria—Doxorubicin—pancreatic cancer	0.000216	0.00121	CcSEcCtD
Nicardipine—Vomiting—Irinotecan—pancreatic cancer	0.000213	0.00119	CcSEcCtD
Nicardipine—Sinusitis—Doxorubicin—pancreatic cancer	0.000213	0.00119	CcSEcCtD
Nicardipine—Dizziness—Fluorouracil—pancreatic cancer	0.000213	0.00118	CcSEcCtD
Nicardipine—Visual impairment—Epirubicin—pancreatic cancer	0.000212	0.00118	CcSEcCtD
Nicardipine—Rash—Irinotecan—pancreatic cancer	0.000212	0.00118	CcSEcCtD
Nicardipine—Dermatitis—Irinotecan—pancreatic cancer	0.000211	0.00118	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000211	0.00118	CcSEcCtD
Nicardipine—Headache—Irinotecan—pancreatic cancer	0.00021	0.00117	CcSEcCtD
Nicardipine—Insomnia—Docetaxel—pancreatic cancer	0.00021	0.00117	CcSEcCtD
Nicardipine—Paraesthesia—Docetaxel—pancreatic cancer	0.000208	0.00116	CcSEcCtD
Nicardipine—Vomiting—Gemcitabine—pancreatic cancer	0.000208	0.00116	CcSEcCtD
Nicardipine—Dyspnoea—Docetaxel—pancreatic cancer	0.000207	0.00115	CcSEcCtD
Nicardipine—Somnolence—Docetaxel—pancreatic cancer	0.000206	0.00115	CcSEcCtD
Nicardipine—Rash—Gemcitabine—pancreatic cancer	0.000206	0.00115	CcSEcCtD
Nicardipine—Dermatitis—Gemcitabine—pancreatic cancer	0.000206	0.00115	CcSEcCtD
Nicardipine—Tinnitus—Epirubicin—pancreatic cancer	0.000205	0.00114	CcSEcCtD
Nicardipine—Headache—Gemcitabine—pancreatic cancer	0.000205	0.00114	CcSEcCtD
Nicardipine—Flushing—Epirubicin—pancreatic cancer	0.000204	0.00114	CcSEcCtD
Nicardipine—Vomiting—Fluorouracil—pancreatic cancer	0.000204	0.00114	CcSEcCtD
Nicardipine—Rhinitis—Doxorubicin—pancreatic cancer	0.000204	0.00114	CcSEcCtD
Nicardipine—Dyspepsia—Docetaxel—pancreatic cancer	0.000204	0.00114	CcSEcCtD
Nicardipine—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000203	0.00113	CcSEcCtD
Nicardipine—Rash—Fluorouracil—pancreatic cancer	0.000203	0.00113	CcSEcCtD
Nicardipine—Dermatitis—Fluorouracil—pancreatic cancer	0.000203	0.00113	CcSEcCtD
Nicardipine—Headache—Fluorouracil—pancreatic cancer	0.000201	0.00112	CcSEcCtD
Nicardipine—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000201	0.00112	CcSEcCtD
Nicardipine—Nausea—Irinotecan—pancreatic cancer	0.000199	0.00111	CcSEcCtD
Nicardipine—Constipation—Docetaxel—pancreatic cancer	0.000198	0.00111	CcSEcCtD
Nicardipine—Pain—Docetaxel—pancreatic cancer	0.000198	0.00111	CcSEcCtD
Nicardipine—Visual impairment—Doxorubicin—pancreatic cancer	0.000196	0.00109	CcSEcCtD
Nicardipine—Nausea—Gemcitabine—pancreatic cancer	0.000194	0.00108	CcSEcCtD
Nicardipine—Feeling abnormal—Docetaxel—pancreatic cancer	0.000191	0.00107	CcSEcCtD
Nicardipine—Nausea—Fluorouracil—pancreatic cancer	0.000191	0.00106	CcSEcCtD
Nicardipine—Tinnitus—Doxorubicin—pancreatic cancer	0.00019	0.00106	CcSEcCtD
Nicardipine—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.00019	0.00106	CcSEcCtD
Nicardipine—Flushing—Doxorubicin—pancreatic cancer	0.000189	0.00105	CcSEcCtD
Nicardipine—Tension—Epirubicin—pancreatic cancer	0.000188	0.00105	CcSEcCtD
Nicardipine—Nervousness—Epirubicin—pancreatic cancer	0.000186	0.00104	CcSEcCtD
Nicardipine—Abdominal pain—Docetaxel—pancreatic cancer	0.000183	0.00102	CcSEcCtD
Nicardipine—Body temperature increased—Docetaxel—pancreatic cancer	0.000183	0.00102	CcSEcCtD
Nicardipine—Vision blurred—Epirubicin—pancreatic cancer	0.000181	0.00101	CcSEcCtD
Nicardipine—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000178	0.000991	CcSEcCtD
Nicardipine—Agitation—Epirubicin—pancreatic cancer	0.000176	0.000982	CcSEcCtD
Nicardipine—Tension—Doxorubicin—pancreatic cancer	0.000174	0.00097	CcSEcCtD
Nicardipine—Malaise—Epirubicin—pancreatic cancer	0.000173	0.000963	CcSEcCtD
Nicardipine—Nervousness—Doxorubicin—pancreatic cancer	0.000172	0.00096	CcSEcCtD
Nicardipine—Vertigo—Epirubicin—pancreatic cancer	0.000172	0.00096	CcSEcCtD
Nicardipine—Syncope—Epirubicin—pancreatic cancer	0.000172	0.000958	CcSEcCtD
Nicardipine—Hypersensitivity—Docetaxel—pancreatic cancer	0.000171	0.000952	CcSEcCtD
Nicardipine—Palpitations—Epirubicin—pancreatic cancer	0.000169	0.000944	CcSEcCtD
Nicardipine—Loss of consciousness—Epirubicin—pancreatic cancer	0.000169	0.000939	CcSEcCtD
Nicardipine—Vision blurred—Doxorubicin—pancreatic cancer	0.000167	0.000932	CcSEcCtD
Nicardipine—Asthenia—Docetaxel—pancreatic cancer	0.000166	0.000927	CcSEcCtD
Nicardipine—Hypertension—Epirubicin—pancreatic cancer	0.000166	0.000922	CcSEcCtD
Nicardipine—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000165	0.000917	CcSEcCtD
Nicardipine—Chest pain—Epirubicin—pancreatic cancer	0.000163	0.00091	CcSEcCtD
Nicardipine—Arthralgia—Epirubicin—pancreatic cancer	0.000163	0.00091	CcSEcCtD
Nicardipine—Myalgia—Epirubicin—pancreatic cancer	0.000163	0.00091	CcSEcCtD
Nicardipine—Agitation—Doxorubicin—pancreatic cancer	0.000163	0.000908	CcSEcCtD
Nicardipine—Anxiety—Epirubicin—pancreatic cancer	0.000163	0.000906	CcSEcCtD
Nicardipine—Discomfort—Epirubicin—pancreatic cancer	0.000161	0.000899	CcSEcCtD
Nicardipine—Malaise—Doxorubicin—pancreatic cancer	0.00016	0.000891	CcSEcCtD
Nicardipine—Dry mouth—Epirubicin—pancreatic cancer	0.00016	0.00089	CcSEcCtD
Nicardipine—Vertigo—Doxorubicin—pancreatic cancer	0.000159	0.000888	CcSEcCtD
Nicardipine—Syncope—Doxorubicin—pancreatic cancer	0.000159	0.000886	CcSEcCtD
Nicardipine—Diarrhoea—Docetaxel—pancreatic cancer	0.000159	0.000884	CcSEcCtD
Nicardipine—Confusional state—Epirubicin—pancreatic cancer	0.000158	0.000879	CcSEcCtD
Nicardipine—Palpitations—Doxorubicin—pancreatic cancer	0.000157	0.000874	CcSEcCtD
Nicardipine—Oedema—Epirubicin—pancreatic cancer	0.000157	0.000872	CcSEcCtD
Nicardipine—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000156	0.000869	CcSEcCtD
Nicardipine—Infection—Epirubicin—pancreatic cancer	0.000155	0.000866	CcSEcCtD
Nicardipine—Shock—Epirubicin—pancreatic cancer	0.000154	0.000858	CcSEcCtD
Nicardipine—Dizziness—Docetaxel—pancreatic cancer	0.000153	0.000855	CcSEcCtD
Nicardipine—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000153	0.000854	CcSEcCtD
Nicardipine—Hypertension—Doxorubicin—pancreatic cancer	0.000153	0.000853	CcSEcCtD
Nicardipine—Tachycardia—Epirubicin—pancreatic cancer	0.000153	0.000851	CcSEcCtD
Nicardipine—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000151	0.000843	CcSEcCtD
Nicardipine—Chest pain—Doxorubicin—pancreatic cancer	0.000151	0.000842	CcSEcCtD
Nicardipine—Arthralgia—Doxorubicin—pancreatic cancer	0.000151	0.000842	CcSEcCtD
Nicardipine—Myalgia—Doxorubicin—pancreatic cancer	0.000151	0.000842	CcSEcCtD
Nicardipine—Anxiety—Doxorubicin—pancreatic cancer	0.000151	0.000839	CcSEcCtD
Nicardipine—Discomfort—Doxorubicin—pancreatic cancer	0.000149	0.000831	CcSEcCtD
Nicardipine—Dry mouth—Doxorubicin—pancreatic cancer	0.000148	0.000823	CcSEcCtD
Nicardipine—Vomiting—Docetaxel—pancreatic cancer	0.000148	0.000822	CcSEcCtD
Nicardipine—Rash—Docetaxel—pancreatic cancer	0.000146	0.000815	CcSEcCtD
Nicardipine—Hypotension—Epirubicin—pancreatic cancer	0.000146	0.000815	CcSEcCtD
Nicardipine—Dermatitis—Docetaxel—pancreatic cancer	0.000146	0.000814	CcSEcCtD
Nicardipine—Confusional state—Doxorubicin—pancreatic cancer	0.000146	0.000813	CcSEcCtD
Nicardipine—Headache—Docetaxel—pancreatic cancer	0.000145	0.00081	CcSEcCtD
Nicardipine—Oedema—Doxorubicin—pancreatic cancer	0.000145	0.000807	CcSEcCtD
Nicardipine—Infection—Doxorubicin—pancreatic cancer	0.000144	0.000801	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000143	0.000794	CcSEcCtD
Nicardipine—Shock—Doxorubicin—pancreatic cancer	0.000142	0.000794	CcSEcCtD
Nicardipine—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000142	0.00079	CcSEcCtD
Nicardipine—Insomnia—Epirubicin—pancreatic cancer	0.000142	0.000789	CcSEcCtD
Nicardipine—Tachycardia—Doxorubicin—pancreatic cancer	0.000141	0.000787	CcSEcCtD
Nicardipine—Paraesthesia—Epirubicin—pancreatic cancer	0.000141	0.000783	CcSEcCtD
Nicardipine—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.00014	0.00078	CcSEcCtD
Nicardipine—Dyspnoea—Epirubicin—pancreatic cancer	0.00014	0.000777	CcSEcCtD
Nicardipine—Somnolence—Epirubicin—pancreatic cancer	0.000139	0.000775	CcSEcCtD
Nicardipine—Nausea—Docetaxel—pancreatic cancer	0.000138	0.000768	CcSEcCtD
Nicardipine—Dyspepsia—Epirubicin—pancreatic cancer	0.000138	0.000768	CcSEcCtD
Nicardipine—Hypotension—Doxorubicin—pancreatic cancer	0.000135	0.000754	CcSEcCtD
Nicardipine—Constipation—Epirubicin—pancreatic cancer	0.000134	0.000746	CcSEcCtD
Nicardipine—Pain—Epirubicin—pancreatic cancer	0.000134	0.000746	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000132	0.000735	CcSEcCtD
Nicardipine—Insomnia—Doxorubicin—pancreatic cancer	0.000131	0.00073	CcSEcCtD
Nicardipine—Paraesthesia—Doxorubicin—pancreatic cancer	0.00013	0.000724	CcSEcCtD
Nicardipine—Dyspnoea—Doxorubicin—pancreatic cancer	0.000129	0.000719	CcSEcCtD
Nicardipine—Feeling abnormal—Epirubicin—pancreatic cancer	0.000129	0.000718	CcSEcCtD
Nicardipine—Somnolence—Doxorubicin—pancreatic cancer	0.000129	0.000717	CcSEcCtD
Nicardipine—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000128	0.000713	CcSEcCtD
Nicardipine—Dyspepsia—Doxorubicin—pancreatic cancer	0.000127	0.00071	CcSEcCtD
Nicardipine—Pain—Doxorubicin—pancreatic cancer	0.000124	0.00069	CcSEcCtD
Nicardipine—Constipation—Doxorubicin—pancreatic cancer	0.000124	0.00069	CcSEcCtD
Nicardipine—Body temperature increased—Epirubicin—pancreatic cancer	0.000124	0.000689	CcSEcCtD
Nicardipine—Abdominal pain—Epirubicin—pancreatic cancer	0.000124	0.000689	CcSEcCtD
Nicardipine—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000119	0.000665	CcSEcCtD
Nicardipine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000118	0.00066	CcSEcCtD
Nicardipine—Hypersensitivity—Epirubicin—pancreatic cancer	0.000115	0.000642	CcSEcCtD
Nicardipine—Abdominal pain—Doxorubicin—pancreatic cancer	0.000114	0.000638	CcSEcCtD
Nicardipine—Body temperature increased—Doxorubicin—pancreatic cancer	0.000114	0.000638	CcSEcCtD
Nicardipine—Asthenia—Epirubicin—pancreatic cancer	0.000112	0.000626	CcSEcCtD
Nicardipine—Diarrhoea—Epirubicin—pancreatic cancer	0.000107	0.000597	CcSEcCtD
Nicardipine—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000107	0.000594	CcSEcCtD
Nicardipine—Asthenia—Doxorubicin—pancreatic cancer	0.000104	0.000579	CcSEcCtD
Nicardipine—Dizziness—Epirubicin—pancreatic cancer	0.000103	0.000577	CcSEcCtD
Nicardipine—Vomiting—Epirubicin—pancreatic cancer	9.95e-05	0.000554	CcSEcCtD
Nicardipine—Diarrhoea—Doxorubicin—pancreatic cancer	9.91e-05	0.000552	CcSEcCtD
Nicardipine—Rash—Epirubicin—pancreatic cancer	9.87e-05	0.00055	CcSEcCtD
Nicardipine—Dermatitis—Epirubicin—pancreatic cancer	9.86e-05	0.000549	CcSEcCtD
Nicardipine—Headache—Epirubicin—pancreatic cancer	9.8e-05	0.000546	CcSEcCtD
Nicardipine—Dizziness—Doxorubicin—pancreatic cancer	9.58e-05	0.000533	CcSEcCtD
Nicardipine—Nausea—Epirubicin—pancreatic cancer	9.3e-05	0.000518	CcSEcCtD
Nicardipine—Vomiting—Doxorubicin—pancreatic cancer	9.21e-05	0.000513	CcSEcCtD
Nicardipine—Rash—Doxorubicin—pancreatic cancer	9.13e-05	0.000509	CcSEcCtD
Nicardipine—Dermatitis—Doxorubicin—pancreatic cancer	9.12e-05	0.000508	CcSEcCtD
Nicardipine—Headache—Doxorubicin—pancreatic cancer	9.07e-05	0.000505	CcSEcCtD
Nicardipine—Nausea—Doxorubicin—pancreatic cancer	8.6e-05	0.000479	CcSEcCtD
Nicardipine—CALM1—Disease—NRAS—pancreatic cancer	4.45e-06	2.3e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—SRC—pancreatic cancer	4.45e-06	2.3e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—CTNNB1—pancreatic cancer	4.44e-06	2.29e-05	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—PTEN—pancreatic cancer	4.44e-06	2.29e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—KRAS—pancreatic cancer	4.44e-06	2.29e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—CCND1—pancreatic cancer	4.43e-06	2.28e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—CTNNB1—pancreatic cancer	4.43e-06	2.28e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—CCND1—pancreatic cancer	4.42e-06	2.28e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—EGFR—pancreatic cancer	4.39e-06	2.27e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—EGFR—pancreatic cancer	4.39e-06	2.27e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—CTNNB1—pancreatic cancer	4.39e-06	2.26e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—TP53—pancreatic cancer	4.38e-06	2.26e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—CTNNB1—pancreatic cancer	4.37e-06	2.26e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—MMP9—pancreatic cancer	4.36e-06	2.25e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	4.35e-06	2.24e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—PTEN—pancreatic cancer	4.35e-06	2.24e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PIK3CD—pancreatic cancer	4.35e-06	2.24e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—MMP9—pancreatic cancer	4.34e-06	2.24e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—PTEN—pancreatic cancer	4.34e-06	2.24e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—PIK3CA—pancreatic cancer	4.34e-06	2.24e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—VEGFA—pancreatic cancer	4.33e-06	2.24e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—PTEN—pancreatic cancer	4.33e-06	2.23e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—PTEN—pancreatic cancer	4.32e-06	2.23e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—PTEN—pancreatic cancer	4.32e-06	2.23e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—PIK3CA—pancreatic cancer	4.32e-06	2.23e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—PTGS2—pancreatic cancer	4.31e-06	2.22e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—MMP9—pancreatic cancer	4.3e-06	2.22e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—KRAS—pancreatic cancer	4.29e-06	2.21e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—STAT3—pancreatic cancer	4.29e-06	2.21e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—MYC—pancreatic cancer	4.29e-06	2.21e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—MMP9—pancreatic cancer	4.29e-06	2.21e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—NRAS—pancreatic cancer	4.28e-06	2.21e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—TGFB1—pancreatic cancer	4.28e-06	2.21e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—PTEN—pancreatic cancer	4.27e-06	2.21e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—PTEN—pancreatic cancer	4.26e-06	2.2e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—AKT1—pancreatic cancer	4.22e-06	2.18e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—AKT1—pancreatic cancer	4.21e-06	2.17e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—TP53—pancreatic cancer	4.2e-06	2.17e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—EGFR—pancreatic cancer	4.19e-06	2.16e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—HRAS—pancreatic cancer	4.19e-06	2.16e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—PIK3CB—pancreatic cancer	4.18e-06	2.16e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—PTEN—pancreatic cancer	4.18e-06	2.16e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—PTEN—pancreatic cancer	4.18e-06	2.16e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—PIK3CA—pancreatic cancer	4.17e-06	2.15e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—PIK3CA—pancreatic cancer	4.17e-06	2.15e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—AKT1—pancreatic cancer	4.17e-06	2.15e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—AKT1—pancreatic cancer	4.16e-06	2.15e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—TYMS—pancreatic cancer	4.15e-06	2.14e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—KRAS—pancreatic cancer	4.15e-06	2.14e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—KRAS—pancreatic cancer	4.15e-06	2.14e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—MYC—pancreatic cancer	4.15e-06	2.14e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—MYC—pancreatic cancer	4.15e-06	2.14e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—TGFB1—pancreatic cancer	4.14e-06	2.14e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—TGFB1—pancreatic cancer	4.14e-06	2.14e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	4.1e-06	2.11e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—PIK3CA—pancreatic cancer	4.08e-06	2.1e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	4.06e-06	2.1e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—EGFR—pancreatic cancer	4.06e-06	2.09e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—EGFR—pancreatic cancer	4.06e-06	2.09e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—PIK3CB—pancreatic cancer	4.05e-06	2.09e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—PIK3CB—pancreatic cancer	4.05e-06	2.09e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CXCL8—pancreatic cancer	4.02e-06	2.07e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—SRC—pancreatic cancer	4.02e-06	2.07e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—HRAS—pancreatic cancer	4.01e-06	2.07e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—SRC—pancreatic cancer	4e-06	2.07e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—HRAS—pancreatic cancer	3.99e-06	2.06e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—MYC—pancreatic cancer	3.99e-06	2.06e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—TGFB1—pancreatic cancer	3.98e-06	2.05e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—SRC—pancreatic cancer	3.96e-06	2.05e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—KRAS—pancreatic cancer	3.96e-06	2.04e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—SRC—pancreatic cancer	3.95e-06	2.04e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—TP53—pancreatic cancer	3.95e-06	2.04e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—PIK3CA—pancreatic cancer	3.94e-06	2.03e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—VEGFA—pancreatic cancer	3.91e-06	2.02e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—EGFR—pancreatic cancer	3.9e-06	2.01e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—VEGFA—pancreatic cancer	3.9e-06	2.01e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CXCL8—pancreatic cancer	3.89e-06	2.01e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CXCL8—pancreatic cancer	3.89e-06	2.01e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	3.88e-06	2e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—STAT3—pancreatic cancer	3.87e-06	2e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—NRAS—pancreatic cancer	3.86e-06	1.99e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—HRAS—pancreatic cancer	3.86e-06	1.99e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—HRAS—pancreatic cancer	3.86e-06	1.99e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—VEGFA—pancreatic cancer	3.86e-06	1.99e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—STAT3—pancreatic cancer	3.86e-06	1.99e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—NRAS—pancreatic cancer	3.85e-06	1.99e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—VEGFA—pancreatic cancer	3.85e-06	1.99e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PTGS2—pancreatic cancer	3.85e-06	1.99e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CASP3—pancreatic cancer	3.85e-06	1.98e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—KRAS—pancreatic cancer	3.83e-06	1.98e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—KRAS—pancreatic cancer	3.83e-06	1.98e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—STAT3—pancreatic cancer	3.82e-06	1.97e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—PIK3CA—pancreatic cancer	3.81e-06	1.97e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—PIK3CA—pancreatic cancer	3.81e-06	1.97e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—NRAS—pancreatic cancer	3.81e-06	1.97e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—STAT3—pancreatic cancer	3.81e-06	1.97e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—NRAS—pancreatic cancer	3.8e-06	1.96e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PIK3CB—pancreatic cancer	3.79e-06	1.96e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—HRAS—pancreatic cancer	3.77e-06	1.95e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—PTEN—pancreatic cancer	3.76e-06	1.94e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PTGS2—pancreatic cancer	3.76e-06	1.94e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CCND1—pancreatic cancer	3.74e-06	1.93e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CASP3—pancreatic cancer	3.72e-06	1.92e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CASP3—pancreatic cancer	3.72e-06	1.92e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CTNNB1—pancreatic cancer	3.71e-06	1.91e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—AKT1—pancreatic cancer	3.7e-06	1.91e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—KRAS—pancreatic cancer	3.68e-06	1.9e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—HRAS—pancreatic cancer	3.65e-06	1.88e-05	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—PIK3CA—pancreatic cancer	3.64e-06	1.88e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—PIK3CA—pancreatic cancer	3.64e-06	1.88e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MMP9—pancreatic cancer	3.63e-06	1.88e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CCND1—pancreatic cancer	3.62e-06	1.87e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CCND1—pancreatic cancer	3.62e-06	1.87e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—PTEN—pancreatic cancer	3.61e-06	1.86e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—MYC—pancreatic cancer	3.6e-06	1.86e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—TGFB1—pancreatic cancer	3.59e-06	1.85e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—MYC—pancreatic cancer	3.59e-06	1.85e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CTNNB1—pancreatic cancer	3.59e-06	1.85e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CTNNB1—pancreatic cancer	3.59e-06	1.85e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—TGFB1—pancreatic cancer	3.58e-06	1.85e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	3.57e-06	1.84e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—MYC—pancreatic cancer	3.55e-06	1.83e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—AKT1—pancreatic cancer	3.54e-06	1.83e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—TGFB1—pancreatic cancer	3.54e-06	1.83e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—MYC—pancreatic cancer	3.54e-06	1.83e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	3.54e-06	1.83e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PTGS2—pancreatic cancer	3.54e-06	1.83e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—TGFB1—pancreatic cancer	3.53e-06	1.82e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—HRAS—pancreatic cancer	3.53e-06	1.82e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—HRAS—pancreatic cancer	3.53e-06	1.82e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—AKT1—pancreatic cancer	3.53e-06	1.82e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—PIK3CA—pancreatic cancer	3.52e-06	1.82e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—PIK3CA—pancreatic cancer	3.52e-06	1.82e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—EGFR—pancreatic cancer	3.52e-06	1.82e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MMP9—pancreatic cancer	3.52e-06	1.81e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MMP9—pancreatic cancer	3.52e-06	1.81e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PTGS2—pancreatic cancer	3.51e-06	1.81e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—EGFR—pancreatic cancer	3.51e-06	1.81e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—PTEN—pancreatic cancer	3.5e-06	1.8e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—PTEN—pancreatic cancer	3.5e-06	1.8e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—EGFR—pancreatic cancer	3.47e-06	1.79e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—EGFR—pancreatic cancer	3.46e-06	1.79e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—AKT1—pancreatic cancer	3.41e-06	1.76e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—AKT1—pancreatic cancer	3.41e-06	1.76e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—PIK3CA—pancreatic cancer	3.39e-06	1.75e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—APOE—pancreatic cancer	3.38e-06	1.74e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—HRAS—pancreatic cancer	3.37e-06	1.74e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PTEN—pancreatic cancer	3.36e-06	1.73e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—SRC—pancreatic cancer	3.35e-06	1.73e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—AKT1—pancreatic cancer	3.33e-06	1.72e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—KRAS—pancreatic cancer	3.32e-06	1.72e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—KRAS—pancreatic cancer	3.31e-06	1.71e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—KRAS—pancreatic cancer	3.28e-06	1.69e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PTEN—pancreatic cancer	3.28e-06	1.69e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—TP53—pancreatic cancer	3.28e-06	1.69e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—KRAS—pancreatic cancer	3.27e-06	1.69e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—VEGFA—pancreatic cancer	3.26e-06	1.68e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—HRAS—pancreatic cancer	3.26e-06	1.68e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—HRAS—pancreatic cancer	3.26e-06	1.68e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—SRC—pancreatic cancer	3.24e-06	1.67e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—SRC—pancreatic cancer	3.24e-06	1.67e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—STAT3—pancreatic cancer	3.23e-06	1.67e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—NRAS—pancreatic cancer	3.22e-06	1.66e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—AKT1—pancreatic cancer	3.22e-06	1.66e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—VEGFA—pancreatic cancer	3.16e-06	1.63e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—VEGFA—pancreatic cancer	3.16e-06	1.63e-05	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—PIK3CA—pancreatic cancer	3.13e-06	1.62e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—HRAS—pancreatic cancer	3.13e-06	1.62e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—STAT3—pancreatic cancer	3.13e-06	1.61e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—STAT3—pancreatic cancer	3.13e-06	1.61e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—NRAS—pancreatic cancer	3.12e-06	1.61e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—NRAS—pancreatic cancer	3.12e-06	1.61e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—AKT1—pancreatic cancer	3.12e-06	1.61e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—AKT1—pancreatic cancer	3.12e-06	1.61e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PTEN—pancreatic cancer	3.09e-06	1.59e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—PIK3CA—pancreatic cancer	3.07e-06	1.58e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—PIK3CA—pancreatic cancer	3.06e-06	1.58e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PTEN—pancreatic cancer	3.06e-06	1.58e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—PIK3CA—pancreatic cancer	3.05e-06	1.58e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—PIK3CA—pancreatic cancer	3.05e-06	1.57e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	3.05e-06	1.57e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—PIK3CA—pancreatic cancer	3.04e-06	1.57e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—PIK3CA—pancreatic cancer	3.02e-06	1.56e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—PIK3CA—pancreatic cancer	3.01e-06	1.55e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MYC—pancreatic cancer	3e-06	1.55e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—TGFB1—pancreatic cancer	3e-06	1.55e-05	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—AKT1—pancreatic cancer	2.97e-06	1.53e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—AKT1—pancreatic cancer	2.97e-06	1.53e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—TP53—pancreatic cancer	2.96e-06	1.52e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—PIK3CA—pancreatic cancer	2.95e-06	1.52e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—PIK3CA—pancreatic cancer	2.95e-06	1.52e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—TP53—pancreatic cancer	2.95e-06	1.52e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PPARG—pancreatic cancer	2.94e-06	1.52e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—EGFR—pancreatic cancer	2.94e-06	1.52e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—TP53—pancreatic cancer	2.92e-06	1.51e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—TP53—pancreatic cancer	2.91e-06	1.5e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MYC—pancreatic cancer	2.91e-06	1.5e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MYC—pancreatic cancer	2.91e-06	1.5e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—TGFB1—pancreatic cancer	2.9e-06	1.5e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—TGFB1—pancreatic cancer	2.9e-06	1.5e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—AKT1—pancreatic cancer	2.88e-06	1.48e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—AKT1—pancreatic cancer	2.88e-06	1.48e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—EGFR—pancreatic cancer	2.84e-06	1.47e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—EGFR—pancreatic cancer	2.84e-06	1.47e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—HRAS—pancreatic cancer	2.83e-06	1.46e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—HRAS—pancreatic cancer	2.82e-06	1.45e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—HRAS—pancreatic cancer	2.79e-06	1.44e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—HRAS—pancreatic cancer	2.78e-06	1.44e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—KRAS—pancreatic cancer	2.77e-06	1.43e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—AKT1—pancreatic cancer	2.77e-06	1.43e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—KRAS—pancreatic cancer	2.68e-06	1.38e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—KRAS—pancreatic cancer	2.68e-06	1.38e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	2.68e-06	1.38e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	2.65e-06	1.37e-05	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—AKT1—pancreatic cancer	2.56e-06	1.32e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—PIK3CA—pancreatic cancer	2.55e-06	1.32e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—AKT1—pancreatic cancer	2.51e-06	1.29e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—AKT1—pancreatic cancer	2.5e-06	1.29e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—AKT1—pancreatic cancer	2.5e-06	1.29e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—AKT1—pancreatic cancer	2.49e-06	1.29e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—AKT1—pancreatic cancer	2.49e-06	1.28e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—TP53—pancreatic cancer	2.47e-06	1.27e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—PIK3CA—pancreatic cancer	2.47e-06	1.27e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—PIK3CA—pancreatic cancer	2.47e-06	1.27e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—AKT1—pancreatic cancer	2.46e-06	1.27e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—AKT1—pancreatic cancer	2.46e-06	1.27e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—AKT1—pancreatic cancer	2.41e-06	1.24e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—AKT1—pancreatic cancer	2.41e-06	1.24e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—TP53—pancreatic cancer	2.39e-06	1.23e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—TP53—pancreatic cancer	2.39e-06	1.23e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	2.37e-06	1.22e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—HRAS—pancreatic cancer	2.36e-06	1.22e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	2.34e-06	1.2e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PTGS2—pancreatic cancer	2.31e-06	1.19e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PIK3CA—pancreatic cancer	2.31e-06	1.19e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—HRAS—pancreatic cancer	2.28e-06	1.18e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—HRAS—pancreatic cancer	2.28e-06	1.18e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	2.18e-06	1.12e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—AKT1—pancreatic cancer	2.17e-06	1.12e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	2.16e-06	1.11e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—AKT1—pancreatic cancer	2.08e-06	1.07e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PTEN—pancreatic cancer	2.02e-06	1.04e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—AKT1—pancreatic cancer	2.01e-06	1.04e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—AKT1—pancreatic cancer	2.01e-06	1.04e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—AKT1—pancreatic cancer	1.93e-06	9.98e-06	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—AKT1—pancreatic cancer	1.89e-06	9.74e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—AKT1—pancreatic cancer	1.78e-06	9.18e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—AKT1—pancreatic cancer	1.76e-06	9.1e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.42e-06	7.34e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.16e-06	6e-06	CbGpPWpGaD
